Table 1.
Disease | Functions | Potential mechanisms | |
---|---|---|---|
Cardiovascular Diseases | CAD | regulate myocardial ischemic reperfusion | modulate arterial blood perfusion [92] |
CAD | inhibit AS | decrease inflammatory cytokines and improving mitochondrial function [94] | |
CAD | reduce AS | induce autophagy [95, 96] | |
CAD | attenuate AS | antagonize platelet aggregation [96] | |
CAD | protect from AS | promote conversion of PHBP [97] | |
CAD | inhibit AS | activate eNOS [98] | |
EH | inhibit EH | regulate NMDA and its receptors [100] | |
EH | reduce blood pressure | improve age-related diastolic [101] | |
EH | inhibit EH | regulate angiotensin II [103] | |
HF | delay HF | prevent cardiac hypertrophy and protect cardiomyocytes [15, 101] | |
HF | attenuate HF | attenuate mitochondrial dysfunction [105] | |
HF | protect cardiac | reduce telomere attrition [106] | |
HF | protect cardiac | regulate apoptosis of myocardial ischemic cells [107] | |
Neurodegenerative Diseases | AD | reduce memory decline | induce autophagy [110, 111] |
AD | ameliorate dementia | prevent inflammation and apoptosis of nerve cells [44] | |
AD | influence memory | stimulate neural actions [112] | |
PD | protect from PD | maintain the mitochondria in dopaminergic neurons function [113] | |
PD | protect against PD | induce autophagy [114] | |
PD | protect against PD | trigger PINK1-PDR1-dependent mitophagy [115] | |
PD | alleviate PD | inhibit α-synuclein and promote climbing activity [116, 117] | |
PD | protect against PD | exert anti-inflammatory and antioxidant properties [118] | |
PD | attenuate PD | regulate SAT1 activity [119] | |
Metabolic Diseases | T2DM | prevent T2DM | improve insulin sensitivity and maintain glucose homeostasis [120] |
T2DM | prevent T2DM | promote facultative cell proliferation and maintain glucose homeostasis [121] | |
T2DM | prevent diabetic complications | inhibit lipid peroxidation, hemoglobin glycation [122] | |
T2DM | reduce hyperglycemic | enhance glucose utilization [123] | |
T2DM | reduce nephropathy complications | reduce renal collagen [125] | |
Obesity | ameliorate obesity | reduce adiposity and hepatic fat accumulation [120] | |
Obesity | loss of weight | regulate lipid metabolism, inflammatory response, and thermogenesis [70] | |
Obesity | attenuate obesity | induce autophagy in white adipose tissue [126] | |
Obesity | alleviate obesity | enhance intestinal barrier function and alternate microbiota composition [127] | |
Obesity | reduce adiposity | inhibit lipogenic genes expression [69] | |
Obesity | attenuate obesity | increase energy expenditure [128] | |
Metabolic syndrome |
correct metabolic syndrome | activate TETA [129] | |
Metabolic syndrome |
inhibit metabolic syndrome | ameliorate hepatic steatosis and adipose tissue inflammation [70] | |
Musculoskeletal Diseases | Osteoporosis | enhance bone strength | promote warmth regeneration [130] |
Osteoporosis | prevent bone loss | disturb osteoclastic activation [131, 132] | |
Osteoporosis | reduce migration and osteoclastogensis | inhibit RANKLE-mediated signaling pathway, prevent transcription factors [133] | |
Sarcopenia | ameliorate skeletal muscle atrophy | regulate skeletal muscle differentiation [54] | |
Sarcopenia | ameliorate muscle defects | induce autophagy [135] | |
Osteoarthritis | improve osteoarthritis | activate autophagy [136] | |
Osteoarthritis | alleviate synovitis, osteophyte formation and cartilage degeneration | inhibit TNF-α induced NF-κB/p65 signaling pathway [137] | |
Osteoarthritis | protect chondrocytes | reduce oxidant and inflammatory responses [138] | |
Immune Diseases | influenza | improve CD8+ T cell responses | induce autophagy [140] |
cytomegalovirus infection | improve CD8+ T cell responses | induce autophagy [140] | |
colitis | attenuate pathology | promote homeostasis differentiation of regulatory T cells [138] | |
IBD | attenuate inflammation | induce autophagy [141] |
CAD: coronary artery disease; AS: atherosclerosis; EH: essential hypertension; HF: heart failure; AD: Alzheimer's disease; PD: Parkinson’s disease; T2DM: type 2 diabetes mellitus; PHBP: plasma hyaluronan-binding protein; eNOS: endothelial nitric oxide synthase; NMDA: N-methyl-D-aspartate; SAT1: Spermidine/spermine N1-acetyltransferase; TETA: Triethylenetetramine dihydrochloride; TNF-α: tumor necrosis factor-α; NF-κB: nuclear factor kappa-B